While large-scale randomized controlled trials specifically measuring anxiety in tirzepatide users are still emerging, the underlying neurobiology is well-supported by neuropharmacology research
Through a series of human clinical trials, Amarasate has been proven to reduce caloric intake an average of 18%, reduce overall hunger 30% and reduce overall cravings 40%
Other potential dietary triggers include cow's milk, wheat, eggs, alcohol, artificial sweeteners, citrus fruits, pickled products, and vinegar (Mueller 2007
(2013) Genome array of hair follicle genes in lambskin with different patterns
Though originally developed for diabetes treatment, it has gained attention for its superior weight loss outcomes compared to many other medications in its class
PMID: 19426507, PMCID: PMC2690576, DOI: 10.1186/1748-5908-4-25